SNX2, a protein integral to the endosomal sorting process and the retromer complex, is modulated by a variety of chemical compounds that affect cellular trafficking and sorting pathways. Forskolin, by increasing cAMP levels, can potentially enhance SNX2's involvement in endosomal sorting, as cAMP levels are known to influence endosomal dynamics. Similarly, Chloroquine, through its role in altering endosomal pH, can indirectly augment SNX2's function in endosomal sorting and trafficking, a critical aspect of cellular material transport and recycling. Compounds that affect cellular trafficking and organelle function, such as Monensin A and Bafilomycin A1, also play a significant role in modulating SNX2 activity. Monensin A disrupts Golgi function and endosomal trafficking, potentially enhancing SNX2's role in the retromer complex, crucial for endosome-to-Golgi retrieval. Bafilomycin A1, by inhibiting V-ATPase and affecting endosomal acidification, indirectly boosts SNX2's function in the endosomal sorting complex. Wortmannin, as a PI3K inhibitor, and PD 98059, a MEK inhibitor, also contribute to the modulation of intracellular trafficking pathways that can enhance SNX2's role in endosomal sorting.
Furthermore, Rapamycin, by inhibiting mTOR, indirectly supports SNX2's function in endosomal sorting and trafficking, as mTOR signaling influences various aspects of cellular trafficking. U0126, another MEK inhibitor, similarly enhances SNX2's function in these processes. Additionally, compounds affecting microtubule dynamics, such as Vinblastine and Nocodazole, indirectly enhance SNX2's role in endosomal sorting and trafficking by altering the cellular infrastructure necessary for these processes. Lastly, Lithium Chloride, through its inhibition of GSK-3β, can influence endosomal trafficking and sorting, thereby potentially enhancing the role of SNX2 in the retromer complex and endosomal sorting. Together, these compounds, through their targeted effects on cellular trafficking and sorting pathways, synergistically enhance the functional activity of SNX2, underlining its crucial role in the complex process of intracellular material transport and recycling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, which can influence endosomal sorting and trafficking. This activity potentially enhances SNX2's role in endosomal sorting, as SNX2 is involved in the retromer complex, crucial for endosome-to-Golgi retrieval. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Alters endosomal pH, affecting endosomal sorting and maturation. By modifying the endosomal environment, Chloroquine may indirectly enhance the function of SNX2 in endosomal sorting and trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
A monovalent ionophore that disrupts Golgi function and endosomal trafficking. Monensin A's impact on these cellular processes may indirectly enhance SNX2's role in the retromer complex, important for endosome-to-Golgi retrieval. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits V-ATPase, affecting endosomal acidification and trafficking. This inhibition can indirectly boost SNX2's function in the endosomal sorting complex. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor, affecting intracellular trafficking pathways. Wortmannin's influence on these pathways can indirectly enhance the role of SNX2 in endosomal sorting. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor, indirectly influencing endosomal sorting pathways, which can enhance SNX2's function in these processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, affecting various cellular processes including endosomal trafficking. Rapamycin can indirectly enhance the functional role of SNX2 in endosomal sorting and trafficking. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Disrupts microtubule dynamics, affecting intracellular trafficking. Vinblastine's effect on microtubule dynamics can indirectly enhance SNX2's role in endosomal sorting and trafficking, by altering the cellular trafficking infrastructure. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Another microtubule destabilizing agent, impacting intracellular trafficking. Nocodazole's effect on microtubule dynamics can indirectly boost SNX2's function in endosomal sorting and trafficking. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, which can influence endosomal trafficking and sorting. Lithium Chloride's impact on these pathways may enhance the role of SNX2 in the retromer complex and endosomal sorting. | ||||||